Your browser doesn't support javascript.
loading
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence.
Sinicrope, Frank A; Nelson, Garth D; Saberzadeh-Ardestani, Bahar; Segovia, Diana I; Graham, Rondell P; Wu, Christina; Hagen, Catherine E; Shivji, Sameer; Savage, Paul; Buchanan, Dan D; Jenkins, Mark A; Phipps, Amanda I; Swallow, Carol; LeMarchand, Loic; Gallinger, Steven; Grant, Robert C; Pai, Reetesh K; Sinicrope, Stephen N; Yan, Dongyao; Shanmugam, Kandavel; Conner, James; Cyr, David P; Kirsch, Richard; Banerjee, Imon; Alberts, Steve R; Shi, Qian; Pai, Rish K.
Afiliação
  • Sinicrope FA; Departments of Medicine and Oncology, Rochester, Minnesota.
  • Nelson GD; Gastrointestinal Research Unit, Mayo Clinic, Rochester, Minnesota.
  • Saberzadeh-Ardestani B; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
  • Segovia DI; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Graham RP; Gastrointestinal Research Unit, Mayo Clinic, Rochester, Minnesota.
  • Wu C; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
  • Hagen CE; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Shivji S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Savage P; Division of Medical Oncology, Mayo Clinic, Phoenix, Arizona.
  • Buchanan DD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Jenkins MA; Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Phipps AI; Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Swallow C; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • LeMarchand L; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Gallinger S; Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Grant RC; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Pai RK; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sinicrope SN; Department of Epidemiology, University of Washington, Seattle, Washington.
  • Yan D; Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.
  • Shanmugam K; Department of Epidemiology, University of Hawaii, Honolulu, Hawaii.
  • Conner J; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Cyr DP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Kirsch R; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Banerjee I; University of Chicago Medical Center, Chicago, Illinois.
  • Alberts SR; Roche Tissue Diagnostics, Tucson, Arizona.
  • Shi Q; Roche Tissue Diagnostics, Tucson, Arizona.
  • Pai RK; Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Cancer Res Commun ; 4(5): 1344-1350, 2024 May 23.
Article em En | MEDLINE | ID: mdl-38709069
ABSTRACT
Deep learning may detect biologically important signals embedded in tumor morphologic features that confer distinct prognoses. Tumor morphologic features were quantified to enhance patient risk stratification within DNA mismatch repair (MMR) groups using deep learning. Using a quantitative segmentation algorithm (QuantCRC) that identifies 15 distinct morphologic features, we analyzed 402 resected stage III colon carcinomas [191 deficient (d)-MMR; 189 proficient (p)-MMR] from participants in a phase III trial of FOLFOX-based adjuvant chemotherapy. Results were validated in an independent cohort (176 d-MMR; 1,094 p-MMR). Association of morphologic features with clinicopathologic variables, MMR, KRAS, BRAFV600E, and time-to-recurrence (TTR) was determined. Multivariable Cox proportional hazards models were developed to predict TTR. Tumor morphologic features differed significantly by MMR status. Cancers with p-MMR had more immature desmoplastic stroma. Tumors with d-MMR had increased inflammatory stroma, epithelial tumor-infiltrating lymphocytes (TIL), high-grade histology, mucin, and signet ring cells. Stromal subtype did not differ by BRAFV600E or KRAS status. In p-MMR tumors, multivariable analysis identified tumor-stroma ratio (TSR) as the strongest feature associated with TTR [HRadj 2.02; 95% confidence interval (CI), 1.14-3.57; P = 0.018; 3-year recurrence 40.2% vs. 20.4%; Q1 vs. Q2-4]. Among d-MMR tumors, extent of inflammatory stroma (continuous HRadj 0.98; 95% CI, 0.96-0.99; P = 0.028; 3-year recurrence 13.3% vs. 33.4%, Q4 vs. Q1) and N stage were the most robust prognostically. Association of TSR with TTR was independently validated. In conclusion, QuantCRC can quantify morphologic differences within MMR groups in routine tumor sections to determine their relative contributions to patient prognosis, and may elucidate relevant pathophysiologic mechanisms driving prognosis.

SIGNIFICANCE:

A deep learning algorithm can quantify tumor morphologic features that may reflect underlying mechanisms driving prognosis within MMR groups. TSR was the most robust morphologic feature associated with TTR in p-MMR colon cancers. Extent of inflammatory stroma and N stage were the strongest prognostic features in d-MMR tumors. TIL density was not independently prognostic in either MMR group.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Reparo de Erro de Pareamento de DNA / Microambiente Tumoral / Aprendizado Profundo / Recidiva Local de Neoplasia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Commun Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Reparo de Erro de Pareamento de DNA / Microambiente Tumoral / Aprendizado Profundo / Recidiva Local de Neoplasia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Commun Ano de publicação: 2024 Tipo de documento: Article